Moderna and Drug Discovery With AI

In banking, the AI question isn’t “Can you build it?” — it’s “Can you explain it, monitor it, and shut it off when required?” As the hype cycle moves past chatbots, a real competitive divide is emerging: institutions that can operationalize AI with auditability and control versus ...  Show more

Lumentum CEO Michael Hurlston and VP of Investor Relations Kathy Ta join Bloomberg Intelligence’s Jake Silverman on this episode of the Tech Disruptors podcast to discuss how optics are playing an increasingly critical role in networking inside and across AI data centers. They ex ...  Show more

Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ...  Show more

In this episode of the AI Grand Rounds podcast, Dr. James Zou shares his personal journey to discovering machine learning during his graduate studies at Harvard. Fascinated by the potential of AI and its application to geno ...

Artificial intelligence is teaming up with crowdsourcing to improve the thermo-stability of mRNA vaccines, making distribution more accessible worldwide. In this episode of NVIDIA's AI podcast, host Noah Kravitz interviewed Bojan Tunguz, a physicist and senior system software en ...  Show more

Will truth and reason survive the evolution of artificial intelligence? AI researcher Gary Marcus says no, not if untrustworthy technology continues to be integrated into our lives at such dangerously high speeds. He advocates for an urgent reevaluation of whether we're building ...  Show more